Wednesday, June 10, 2026

Drug profile · INN

amlodipine + valsartan

amlodipine + valsartan (AMLODIPINE/VALSARTAN NOVARTIS 10/320) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.

TGA: approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — amlodipine + valsartan

Quick answer

amlodipine + valsartan (AMLODIPINE/VALSARTAN NOVARTIS 10/320) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.

Key facts

INN amlodipine + valsartan
Brand AMLODIPINE/VALSARTAN NOVARTIS 10/320

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. Randomized for not applicable (submitted trial is bioavailability) Phase 1 · Anaxis Pharma · not applicable (submitted trial is bioavailability)
  2. 80% Oxygen Approved · Chinese Academy of · Oxygenation Index
  3. TKC202505 Unknown · University of Hong · Intracerebral Hemorrhage

Frequently asked questions

What is amlodipine + valsartan?

amlodipine + valsartan (AMLODIPINE/VALSARTAN NOVARTIS 10/320) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.

What is the brand name for amlodipine + valsartan?

AMLODIPINE/VALSARTAN NOVARTIS 10/320 is a marketed brand name for amlodipine + valsartan. Check FDA Drugs@FDA for the current US label holder and prescribing information.